Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Capital Leases (2016 - 2019)

Achieve Life Sciences (ACHV) has disclosed Capital Leases for 10 consecutive years, with $20000.0 as the latest value for Q2 2019.

  • Quarterly Capital Leases rose 11.11% to $20000.0 in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $20000.0 through Jun 2019, up 11.11% year-over-year, with the annual reading at $12000.0 for FY2018, N/A changed from the prior year.
  • Capital Leases for Q2 2019 was $20000.0 at Achieve Life Sciences, down from $24000.0 in the prior quarter.
  • The five-year high for Capital Leases was $130000.0 in Q2 2015, with the low at $12000.0 in Q4 2018.
  • Average Capital Leases over 5 years is $58187.5, with a median of $40500.0 recorded in 2016.
  • The widest YoY moves for Capital Leases: up 650.0% in 2015, down 96.14% in 2015.
  • Achieve Life Sciences' Capital Leases stood at $105000.0 in 2015, then plummeted by 53.33% to $49000.0 in 2016, then plummeted by 67.35% to $16000.0 in 2017, then dropped by 25.0% to $12000.0 in 2018, then soared by 66.67% to $20000.0 in 2019.
  • Per Business Quant, the three most recent readings for ACHV's Capital Leases are $20000.0 (Q2 2019), $24000.0 (Q1 2019), and $12000.0 (Q4 2018).